TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TAP Biosystems Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013325
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a medical laboratory that provides laboratory and pharmaceutical equipment. The laboratory offers products such as single-use mini bioreactor systems and automated cell culture systems. It also provides labware, consumables and accessories. TAP offers services including installation, onsite repair services, preventative maintenance, operator and maintenance training, system and software upgrades, lab relocations and decommissioning, protocol development, and validation and GMP compliance. The laboratory’s products are used for drug discovery, biologics production, bioprocess development, regenerative medicine and tissue engineering. It partners with distribution companies. The laboratory operates in Royston, the UK; and Wilmington, the US. TAP is headquartered in Royston, the UK.

TAP Biosystems Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TAP Biosystems Ltd, Medical Devices Deals, 2011 to YTD 2017 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
Licensing Agreements 16
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Acquisition 17
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd – Key Competitors 19
TAP Biosystems Ltd – Key Employees 20
TAP Biosystems Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAP Biosystems Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
TAP Biosystems Ltd, Medical Devices Deals, 2011 to YTD 2017 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd, Key Competitors 19
TAP Biosystems Ltd, Key Employees 20
TAP Biosystems Ltd, Other Locations 21

★海外企業調査レポート[TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CGU Insurance Ltd:企業の戦略・SWOT・財務分析
    CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務情報
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Plansee Holding AG:企業の戦略・SWOT・財務情報
    Plansee Holding AG - Strategy, SWOT and Corporate Finance Report Summary Plansee Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • Silver Spring Networks, Inc. (SSNI)-エネルギー分野:企業M&A・提携分析
    Summary Silver Spring Networks, Inc. (Silver Spring) is a smart grid networking platform technology and solutions provider. The company’s products include metering devices, network infrastructure, utilityIQ applications, GridScape software and customerIQ web portal. Silver Spring provides wide range …
  • Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Boji Medical & Biotechnological Co Ltd (BOJI) is a contract research organization. The organization provides services including regulatory affairs, preclinical research, clinical trials I-IV, PMS, clinical trial for medical devices, post marketing studies (PMS), data management and …
  • Lydall Inc (LDL):企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Siemens AG:企業のM&A・事業提携・投資動向
    Siemens AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hatch Ltd:企業の戦略的SWOT分析
    Hatch Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • Octapharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical …
  • Lagardere SCA:企業の戦略・SWOT・財務情報
    Lagardere SCA - Strategy, SWOT and Corporate Finance Report Summary Lagardere SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enbridge Energy Partners LP (EEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Enbridge Energy Partners LP (EEP) is a midstream energy partnership that owns and operates a diversified portfolio of crude oil and liquids transportation systems in the US. It provides services through interstate pipeline transportation and storage of crude oil and liquid petroleum. The par …
  • Itron Inc (ITRI):企業の財務・戦略的SWOT分析
    Itron Inc (ITRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Diagnostica Stago SAS:企業の戦略的SWOT分析
    Diagnostica Stago SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Shelby Energy Cooperative Inc:企業の戦略的SWOT分析
    Shelby Energy Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • DISH Network Corp (DISH):企業の財務・戦略的SWOT分析
    DISH Network Corp (DISH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • American Midstream Partners LP (AMID):石油・ガス:M&Aディール及び事業提携情報
    Summary American Midstream Partners LP (American Midstream) is an oil and gas company that owns, operates, develops and acquires a diversified portfolio of midstream energy assets. The company’s services include processing, gathering, treating, and transporting of natural gas, fractionating NGLs and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆